share_log

68 Biggest Movers From Wednesday

68 Biggest Movers From Wednesday

週三開始68個最大的轉會
Benzinga Real-time News ·  2021/11/26 05:42

Gainers

贏家

  • AeroClean Technologies, Inc. (NASDAQ:AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
  • Longeveron Inc. (NASDAQ:LGVN) rose 145.6% to settle at $42.30 on Wednesday after tumbling 39% on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
  • Biofrontera Inc. (NASDAQ:BFRI) shares climbed 98.5% to close $5.22 on Wednesday after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
  • IM Cannabis Corp. (NASDAQ:IMCC) gained 37.8% to settle at $4.30. IM Cannabis recently announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%.
  • Local Bounti Corporation (NYSE:LOCL) surged 32.6% to close at $10.62.
  • Blue Star Foods Corp. (NASDAQ:BSFC) gained 29.9% to settle at $3.65. Blue Star Foods recently reported $3.73 million in quarterly sales.
  • Spark Networks SE (NYSE:LOV) jumped 23.6% to close at $3.30. Spark Networks 10% owner Osmium Diamond Lp acquired a total of 1654197 shares at an average price of $2.51.
  • Femasys Inc. (NASDAQ:FEMY) gained 22.9% to settle at $4.99. Femasys recently posted Q3 loss of $0.19 per share.
  • Standard Lithium Ltd. (NYSE:SLI) surged 22.2% to close at $10.63 after the company announced a $100 million direct investment from Koch Strategic Platforms.
  • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) gained 22.1% to settle at $2.65.
  • Trio-Tech International (NYSE:TRT) jumped 21.5% to close at $10.75.
  • Trio-Tech recently reported Q1 results, posting a 49% year-over-year increase in total revenue.
  • Grom Social Enterprises, Inc. (NASDAQ:GROM) rose 20.9% to close at $2.72. Grom Social Enterprises disclosed that its newest division, Curiosity Ink Media, unwrapped Santa.com.
  • Dermata Therapeutics, Inc. (NASDAQ:DRMA) gained 20.6% to settle at $2.81. Dermata Therapeutics recently announced data from its Phase 1b proof of concept study evaluating a single treatment of DMT410 to treat multiple aesthetic skin conditions.
  • Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 19.8% to close at $3.81 after the company reported Q4 2021 and FY21 revenue was higher year over year.
  • IDW Media Holdings, Inc. (NYSE:IDW) gained 19.3% to close at $2.60.
  • Better Therapeutics, Inc. (NASDAQ:BTTX) shares rose 19.1% to close at $7.68 after Chardan Capital initiated coverage on the stock with a Buy rating and a $17 price target.
  • Augmedix, Inc. (NASDAQ:AUGX) gained 19% to settle at $3.45. Augmedix recently posted a Q3 net loss of $2.859 million.
  • Ocuphire Pharma, Inc. (NASDAQ:OCUP) gained 18.8% to close at $4.1350 after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol Eye Drops in the reversal of pharmacologically-induced mydriasis.
  • Society Pass Incorporated (NASDAQ:SOPA) jumped 17.8% to settle at $13.17 amid continued volatility following the stock's IPO earlier in the month.
  • ForgeRock, Inc. (NYSE:FORG) gained 17.6% to close at $29.14. The company recently posted upbeat quarterly results.
  • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) gained 17.2% to close at $7.10. MyMD Pharma Form 4 filing showed the company’s VP of Operations Paul Rivard bought 15,000 shares of co. stock on Nov. 23.
  • Nxt-ID, Inc. (NASDAQ:NXTD) gained 17% to close at $3.10.
  • Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) jumped 16.9% to settle at $31.50.
  • Finch Therapeutics Group, Inc. (NASDAQ:FNCH) gained 16.3% to close at $15.74. Finch Therapeutics Group recently announced positive topline results from PRISM-EXT, an open-label extension of the PRISM3 Phase 2 trial evaluating CP101 to prevent recurrent C. difficile infection (CDI).
  • Global-e Online Ltd. (NASDAQ:GLBE) jumped 15.8% to close at $60.99 after the company announced it will acquire Flow Commerce for an aggregate purchase price of up to approximately $500 million.
  • Paltalk, Inc. (NASDAQ:PALT) gained 15.7% to close at $4.06.
  • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) jumped 15.6% to close at $18.80.
  • Recursion Pharmaceuticals recently reported Q3 earnings results.
  • Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) gained 15.5% to close at $3.43. Brainstorm Cell recently posted Q3 loss of $0.15 per share.
  • Guardant Health, Inc. (NASDAQ:GH) gained 15.5% to close at $107.25 following stock purchases by the company's Co-CEOs.
  • Instil Bio, Inc. (NASDAQ:TIL) gained 14.5% to settle at $19.86
  • Golden Ocean Group Limited (NASDAQ:GOGL) rose 14.1% to close at $9.12 after reporting Q3 results.
  • Foghorn Therapeutics Inc. (NASDAQ:FHTX) gained 14.1% to close at $14.21. HC Wainwright & Co. recently initiated coverage on Foghorn Therapeutics with a Buy rating and announced a price target of $25.
  • Pure Storage, Inc. (NASDAQ:PSTG) climbed 13.5% to settle at $30.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY22 sales guidance above estimates.
  • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) gained 13.2% to close at $3.85. Reviva Pharmaceuticals recently posted a Q3 loss of $0.12 per share.
  • BIOLASE, Inc. (NASDAQ:BIOL) rose 11.9% to settle at $0.4700 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit deal.
  • Guess', Inc. (NYSE:GES) gained 11.4% to close at $23.73 after the company reported better-than-expected Q3 EPS and sales results and raised its quarterly dividend.
  • Benessere Capital Acquisition Corp. (NASDAQ:BENE) climbed 10.4% to close at $11.23. eCombustible Energy will merge with Benessere Capital Acquisition Corp. in a $805 million deal.
  • Kidpik Corp. (NASDAQ:PIK) gained 10.3% to close at $6.32. The company recently priced its IPO at $8.50 per share.
  • HP Inc. (NYSE:HPQ) climbed 10.1% to settle at $35.44 after the company reported better-than-expected results for its fourth quarter and issued strong earnings forecast for the current quarter.
  • Bridgeline Digital, Inc. (NASDAQ:BLIN) rose 9.4% to close at $3.04.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 8.3% to close at $3.38.
  • AeroClean Technologies，Inc.納斯達克(Sequoia Capital：AERC)週三股價上漲689.4%，收於78.94美元，此前該公司將首次公開募股價格定為每股10美元。
  • 隆格韋隆公司(Longeveron Inc.)納斯達克(Sequoia Capital：LGVN)週三上漲145.6%，收於42.3美元，週二暴跌39%.該公司上週宣佈，FDA授予Lomecel-B治療左心發育不良綜合徵的罕見兒科疾病稱號。
  • Biofrontera Inc.納斯達克(Standard Chartered Bank：BFRI)股價週三攀升98.5%，收於5.22美元，此前羅斯資本對該股的評級為買入，目標價為20美元。
  • 我是大麻公司。納斯達克(Sequoia Capital：IMCC)上漲37.8%，收於4.3美元。IM Cannabis最近於週一公佈了截至2021年9月30日的三個月和九個月的未經審計的財務業績，收入為1440萬加元(合1150萬美元)，環比增長約30%。
  • 當地邦蒂公司(紐約證券交易所代碼：Locl)暴漲32.6%，收於10.62美元。
  • 藍星食品公司(Blue Star Foods Corp.)納斯達克(Sequoia Capital：BSFC)上漲29.9%，收於3.65美元。藍星食品(Blue Star Foods)最近公佈的季度銷售額為373萬美元。
  • 星火網絡SE(紐約證券交易所股票代碼：LOV)跳漲23.6%，收於3.30美元。星火網絡10%的持有者歐司曼鑽石有限責任公司以2.51%的平均價格收購了總計1654197股。
  • Femasys Inc.納斯達克(Weibo：FAMY)上漲22.9%，收於4.99美元。Femasys最近公佈第三季度每股虧損0.19美元。
  • 標準鋰有限公司(紐約證券交易所代碼：SLI)股價飆升22.2%，收於10.63美元，此前該公司宣佈從科赫戰略平臺獲得1億美元的直接投資。
  • Cyclarie治療公司(Cyclarion Treateutics，Inc.)納斯達克(Weibo：CYCN)上漲22.1%，收於2.65美元。
  • 國際三重技術公司(Trio-Tech International)(紐約證券交易所代碼：TRT)跳漲21.5%，收報10.75美元。
  • Trio-Tech最近公佈了第一季度業績，總收入同比增長49%。
  • 格羅姆社會企業公司納斯達克(Starbucks：Grom)上漲20.9%，收於2.72美元。格羅姆社會企業(Grom Social Enterprise)透露，其最新部門好奇號墨水傳媒(Curiity Ink Media)解開了Santa.com。
  • 皮瑪塔治療公司(Dermata Treateutics，Inc.)納斯達克(Sequoia Capital：DRMA)上漲20.6%，收於2.81美元。皮瑪治療公司最近公佈了其1b期概念驗證研究的數據，該研究評估了DMT410治療多種美容皮膚病的單一療法。
  • Engine Gaming and Media，Inc.納斯達克(GAME：GAME)上漲19.8%，收於3.81美元，此前該公司公佈2021年第四季度和21財年營收同比增長。
  • IDW Media Holdings，Inc.(紐約證券交易所代碼：IDW)上漲19.3%，收於2.60美元。
  • Better Treateutics，Inc.納斯達克(Standard Chardan Capital：BTTX)股價上漲19.1%，收於7.68美元，此前查爾丹資本對該股的評級為買入，目標價為17美元。
  • Augmedix，Inc.納斯達克(Sequoia Capital：AUGX)上漲19%，收於3.45美元。Augmedix最近公佈第三季度淨虧損285.9萬美元。
  • 奧克菲爾製藥公司(Ocuphire Pharma，Inc.)納斯達克(Starbucks：OCUP)股價上漲18.8%，收於4.1350美元，此前該公司宣佈，首批受試者已參加MIRA-3期3期關鍵試驗，評估尼索爾滴眼液逆轉藥物性散瞳的作用。
  • 協會通行證有限公司納斯達克(Sequoia Capital：SOPA)股價上漲17.8%，收於13.17美元，該股本月早些時候上市後持續波動。
  • ForgeRock，Inc.(紐約證券交易所代碼：FORG)上漲17.6%，收於29.14美元。該公司最近公佈了樂觀的季度業績。
  • MyMD製藥公司納斯達克(Sequoia Capital：MYMD)上漲17.2%，收於7.1美元。MyMD Pharma Form 4備案文件顯示，該公司運營副總裁保羅·裏瓦德購買了15,000股公司股票。11月23日的股票。
  • NXT-ID，Inc.納斯達克(Sequoia Capital：NXTD)上漲17%，收於3.1美元。
  • Rani治療控股公司納斯達克(Didi Chuxing：RANI)跳漲16.9%，收於31.5美元。
  • 芬奇治療集團(Finch Treateutics Group，Inc.)納斯達克(Sequoia Capital：FNCH)上漲16.3%，收於15.74美元。芬奇治療集團最近宣佈了PRISM-EXT的陽性背線試驗結果，PRISM-EXT是PRISM3階段2試驗的開放擴展，評估CP101以防止艱難梭菌感染(CDI)復發。
  • 環球電子在線有限公司納斯達克(GLBE：GLBE)跳漲15.8%，收報60.99美元，此前該公司宣佈將以總計約5億美元的價格收購Flow Commerce。
  • PalTalk，Inc.納斯達克(Didi Chuxing：PALT)上漲15.7%，收於4.06美元。
  • 遞歸製藥公司納斯達克(Starbucks：RXRX)跳漲15.6%，收於18.8美元。
  • 遞歸製藥公司(Recursion PharmPharmticals)最近公佈了第三季度收益業績。
  • 頭腦風暴細胞治療公司。納斯達克(Sequoia Capital：BCLI)上漲15.5%，收於3.43美元。頭腦風暴細胞最近公佈第三季度每股虧損0.15美元。
  • Guardant Health，Inc.納斯達克(Sequoia Capital：GH)股價上漲15.5%，收於107.25美元，此前該公司聯席首席執行官買入股票。
  • Instil Bio，Instant，Inc.納斯達克(TIL：TIL)上漲14.5%，收於19.86美元
  • 金海集團有限公司納斯達克(GOGL：GOGL)公佈第三季度財報後，股價上漲14.1%，收於9.12美元。
  • 福格霍恩治療公司(Foghorn Treateutics Inc.)納斯達克(Starbucks：FHTX)上漲14.1%，收於14.21美元。HC Wainwright&Co.最近開始對Foghorn治療公司進行買入評級，並宣佈目標價為25美元。
  • Pure Storage，Inc.納斯達克(Sequoia Capital：PSTG)股價上漲13.5%，收於30.95美元，此前該公司公佈了好於預期的第三季度每股收益和銷售業績，併發布了高於預期的第四季度和22財年銷售指引。
  • Reviva製藥控股公司(Reviva PharmPharmticals Holdings，Inc.)納斯達克(Sequoia Capital：RVPH)上漲13.2%，收於3.85美元。Reviva PharmPharmticals最近公佈第三季度每股虧損0.12美元。
  • Biolase，Inc.納斯達克(Sequoia Capital：BIOL)股價上漲11.9%，收於0.4700美元，此前納斯達克批准該公司延期180天，以滿足最低投標價格要求。該公司還達成了優惠的信貸交易。
  • Guess‘，Inc.(紐約證券交易所代碼：GES)股價上漲11.4%，收於23.73美元，此前該公司公佈了好於預期的第三季度每股收益和銷售業績，並提高了季度股息。
  • 貝內斯爾資本收購公司納斯達克(Weibo：Bene)攀升10.4%，收於11.23美元。ECombusable Energy將與Benessere Capital Acquisition Corp.合併，交易金額為8.05億美元。
  • 基德皮克公司(Kidpik Corp.)納斯達克(Sequoia Capital：PIK)上漲10.3%，收於6.32美元。該公司最近將首次公開募股(IPO)定價為每股8.50美元。
  • 惠普公司惠普(NYSE：HPQ)股價攀升10.1%，收於35.44美元，此前該公司公佈了好於預期的第四季度業績，併發布了強勁的當前季度收益預期。
  • Bridgeline Digital，Inc.納斯達克(Sequoia Capital：BLIN)上漲9.4%，收於3.04美元。
  • 美物科技有限公司納斯達克(Sequoia Capital：WNW)股價上漲8.3%，收於3.38美元。


Check out these big penny stock gainers and losers


看看這些微不足道的股票贏家和輸家

Losers

失敗者

  • Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares fell 31.6% to settle at $1.75 on Wednesday after jumping around 105% on Tuesday.
  • Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 29.8% to close at $11.95. Aptevo Therapeutics shares climbed 163% on Tuesday after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
  • Nordstrom, Inc. (NYSE:JWN) shares fell 29% to close at $22.66 after the company reported worse-than-expected Q3 sales results. Jefferies downgraded Nordstrom from Buy to Hold and lowered the price target from $48 to $30.
  • Pasithea Therapeutics Corp. (NASDAQ:KTTA) declined 28.8% to close at $3.99. Pasithea Therapeutics priced its 8.68 million share private placement at $3.50 per share.
  • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 26.2% to close at $5.39 on Wednesday after jumping over 80% on Tuesday.
  • The Gap, Inc. (NYSE:GPS) fell 24.1% to close at $17.84 after the company reported worse-than-expected Q3 EPS and sales results and cut FY21 adjusted EPS guidance below estimates.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 23.3% to close at $7.69 after surging over 40% on Tuesday.
  • iSpecimen Inc. (NASDAQ:ISPC) fell 22.7% to close at $10.20. iSpecimen shares jumped over 48% on Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 21.8% to close at $1.83 after jumping over 75% on Tuesday.
  • Centogene N.V. (NASDAQ:CNTG) fell 19.2% to close at $7.20. Centogene reported Q3 sales of €30.2 million, down 17% Y/Y, driven by decreasing revenues from COVID-19 testing.
  • MediciNova, Inc. (NASDAQ:MNOV) shares fell 19.2% to close at $3.57 after surging 44% on Tuesday.
  • Outlook Therapeutics, Inc. (NASDAQ:OTLK) fell 18.6% to close at $1.27 after the company reported a $10 million bought deal offering of common stock.
  • TDCX Inc. (NYSE:TDCX) dropped 17.3% to close at $18.72 following Q3 results.
  • Nuvation Bio Inc. (NYSE:NUVB) fell 16.2% to close at $7.75.
  • Kura Oncology, Inc. (NASDAQ:KURA) declined 15.5% to close at $14.02 after the company announced the FDA placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold.
  • Autodesk, Inc. (NASDAQ:ADSK) shares fell 15.5% to close at $256.90. Autodesk reported upbeat results for its third quarter, but issued disappointing guidance. Autodesk said it sees Q4 revenue of $1.185 billion to $1.2 billion and non-GAAP earnings of $1.41 to $1.47 per share.
  • Anaplan, Inc. (NYSE:PLAN) shares fell 15.1% to close at $44.22 after the company reported Q3 earnings results. Piper Sandler downgraded Anaplan from Overweight to Neutral and lowered the price target from $77 to $48.
  • Viomi Technology Co., Ltd (NASDAQ:VIOT) slipped 14% to close at $3.51 following Q3 results.
  • Eliem Therapeutics, Inc. (NASDAQ:ELYM) declined 12.3% to settle at $15.48
  • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 12% to close at $5.05. Clarus Therapeutics shares jumped 43% on Tuesday after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
  • Noah Holdings Limited (NYSE:NOAH) dropped 11.4% to close at $39.03 following Q3 results. JP Morgan downgraded Noah Holdings from Overweight to Neutral and announced a $50 price target.
  • NerdWallet, Inc. (NASDAQ:NRDS) dropped 11.2% to close at $22.59. The company recently priced its IPO at $4 per share.
  • Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 9% to close at $7.09. Gracell Biotechnologies shares gained 22% on Tuesday after the company reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
  • Titan Machinery Inc. (NASDAQ:TITN) declined 8.8% to settle at $34.94. Baird downgraded Titan Machinery from Outperform to Neutral and raised the price target from $37 to $41.
  • Dillard's, Inc. (NYSE:DDS) fell 7.9% to close at $377.67.
  • Citi Trends, Inc. (NASDAQ:CTRN) declined 7.9% to settle at $84.01
  • Abercrombie & Fitch Co. (NYSE:ANF) fell 4.6% to close at $39.25. Abercrombie & Fitch recently reported third-quarter FY21 sales growth of 10% year-on-year, to $905.16 million, beating the analyst consensus of $896.86 million.
  • 誇里根治療公司(Qualigen Treateutics，Inc.)納斯達克(Starbucks：QLGN)股價週三下跌31.6%，收於1.75美元，週二大漲約105%。
  • Aptevo治療公司納斯達克(APVO：APVO)跌29.8%，收報11.95美元。Aptevo治療公司股價週二上漲163%，此前該公司宣佈了評估APVO436治療AML的1b期擴大試驗的臨牀更新。到目前為止觀察到的初步數據包括一次完全緩解。
  • 諾德斯特龍公司(紐約證券交易所代碼：JWN)股價下跌29%，收於22.66美元，此前該公司公佈的第三季度銷售業績遜於預期。Jefferies將諾德斯特龍的評級從買入下調至持有，並將目標價從48美元下調至30美元。
  • 帕西婭治療公司(Pasithea Treateutics Corp.)納斯達克(KTTA：KTTA)下跌28.8%，收於3.99美元。帕西婭治療公司(Pasithea Treeutics)將其868萬股私募定價為每股3.50美元。
  • 瓦隆製藥公司納斯達克(Sequoia Capital：VLON)週三下跌26.2%，收於5.39美元，週二曾躍升逾80%。
  • The Gap，Inc.(紐約證券交易所股票代碼：GPS)下跌24.1%，收於17.84美元，此前該公司公佈的第三季度每股收益和銷售業績遜於預期，並將21財年調整後每股收益指引下調至低於預期。
  • Esperion治療公司納斯達克(Sequoia Capital：ESPR)股價週二飆升逾40%後，下跌23.3%，收於7.69美元。
  • ISpecimen Inc.納斯達克(Sequoia Capital：ISPC)下跌22.7%，收於10.20美元。在宣佈簽約支持新冠肺炎新的高級研究後，iSpecimen的股價週二上漲超過48%，該公司宣佈已經簽約支持微博的新的高級研究，尋求對微博的傳播性、變種、結果和在多個人羣中測試有效性的見解。
  • Petros製藥公司納斯達克(Starbucks：PTPI)週二跳漲逾75%後下跌21.8%，收報1.83美元。
  • 新澤西州森特吉納斯達克(Standard Chartered Bank：CNTG)下跌19.2%，收於7.2美元。Centogene報告第三季度銷售額為3020萬歐元，同比下降17%，原因是新冠肺炎測試收入下降。
  • MediciNova，Inc.納斯達克(Sequoia Capital：MNOV)股價週二大漲44%後，下跌19.2%，收於3.57美元。
  • Outlook治療公司納斯達克(Starbucks：OTLK)股價下跌18.6%，收於1.27美元，此前該公司公佈以1,000萬美元買入普通股。
  • TDCX Inc.(紐約證券交易所代碼：TDCX)在第三季度業績公佈後下跌17.3%，收於18.72美元。
  • Nuvation Bio Inc.(紐約證券交易所代碼：NUVB)下跌16.2%，收於7.75美元。
  • 庫拉腫瘤公司納斯達克(KURA)股價下跌15.5%，收於14.02美元，此前該公司宣佈美國食品和藥物管理局(FDA)將KO-539在復發或難治性急性髓細胞白血病(AML)患者中的KOMET-001b期研究部分臨牀擱置。
  • 歐特克公司納斯達克(Sequoia Capital：ADSK)股價下跌15.5%，收於256.90美元。歐特克公佈了樂觀的第三季度業績，但發佈了令人失望的指引。歐特克表示，預計第四季度營收為11.85億至12億美元，非GAAP每股收益為1.41至1.47美元。
  • Anaplan，Inc.(紐約證券交易所股票代碼：PLAN)股價下跌15.1%，收於44.22美元，此前該公司公佈了第三季度收益業績。Piper Sandler將Anaplan評級從加碼下調至中性，目標價從77美元下調至48美元。
  • 雲米科技股份有限公司納斯達克(Sequoia Capital：VIOT)第三季度財報公佈後，股價下跌14%，收於3.51美元。
  • 埃利姆治療公司納斯達克(Sequoia Capital：ELYM)下跌12.3%，收於15.48美元
  • 克拉魯斯治療控股公司(Clarus Treateutics Holdings，Inc.)納斯達克(Starbucks：CRXT)股價下跌12%，收於5.05美元。克拉魯斯治療公司(Clarus Treeutics)週二股價上漲43%，此前該公司獲得了一項名為“口服睾酮酯配方和治療睾酮缺乏症的方法”的美國專利。
  • 諾亞財富有限公司(紐約證券交易所股票代碼：NOAH)第三季度財報公佈後，該公司股價下跌11.4%，收於39.03美元。(投行觀點)摩根大通將諾亞財富評級從加碼下調至中性，並宣佈目標價為50美元
  • NerdWallet，Inc.納斯達克(Starbucks：NRDS)下跌11.2%，收於22.59美元。該公司最近將首次公開募股(IPO)定價為每股4美元。
  • 亙喜生物(Sequoia Capital Inc.)納斯達克(GRCL：GRCL)下跌9%，收於7.09美元。亙喜生物週二股價上漲22%，此前該公司報道稱，其高級管理團隊成員打算在未來3個月內利用個人資金在公開市場購買高達200萬美元的公司美國存託憑證。
  • 泰坦機械公司納斯達克(Starbucks：TITN)下跌8.8%，收於34.94美元。Baird將泰坦機械評級從跑贏大盤下調至中性，並將目標價從37美元上調至41美元。
  • 迪拉德公司(Dillard‘s，Inc.)(紐約證券交易所代碼：DDS)下跌7.9%，收於377.67美元。
  • 花旗趨勢公司(Citi Trends，Inc.)納斯達克(Sequoia Capital：CTRN)下跌7.9%，收於84.01美元
  • Abercrombie&Fitch Co.(紐約證券交易所代碼：ANF)下跌4.6%，收於39.25美元。Abercrombie&Fitch最近公佈，2011財年第三季度銷售額同比增長10%，至9.0516億美元，超出分析師一致預期的8.9686億美元。

 

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論